Gastroretentive fibrous dosage forms for prolonged delivery of sparingly-soluble tyrosine kinase inhibitors. Part 4: Experimental validation of the models of drug concentration in blood
Blaesi, Aron H., Richter, Henning, Saka, Nannaji
Published in International journal of pharmaceutics (19.06.2024)
Published in International journal of pharmaceutics (19.06.2024)
Get full text
Journal Article
Gastroretentive fibrous dosage forms for prolonged delivery of sparingly-soluble tyrosine kinase inhibitors. Part 4: Experimental validation of the models of in vivo expansion, gastric residence time, and drug concentration in blood
Blaesi, Aron H, Richter, Henning, Saka, Nannaji
Published in International journal of pharmaceutics (25.03.2024)
Published in International journal of pharmaceutics (25.03.2024)
Get full text
Journal Article
Withdrawal notice to: “Gastroretentive fibrous dosage forms for prolonged delivery of sparingly soluble tyrosine kinase inhibitors. Part 3: Theoretical models of in vivo expansion, gastric residence time, and drug concentration in blood” [Int. J. Pharm. 653 (2024) 123478]
Get full text
Journal Article
Withdrawal notice to: “Gastroretentive fibrous dosage forms for prolonged delivery of sparingly soluble tyrosine kinase inhibitors. Part 2: Experimental validation of the models of expansion, mechanical strength, and in vitro drug release” [Int. J. Pharm. 653 (2024) 123429]
Get full text
Journal Article
Withdrawal notice to: “Gastroretentive fibrous dosage forms for prolonged delivery of sparingly-soluble tyrosine kinase inhibitors. Part 4: Experimental validation of the models of in vivo expansion, gastric residence time, and drug concentration in blood” [Int. J. Pharm. 653 (2024) 123479]
Get full text
Journal Article
Withdrawal notice to: “Gastroretentive fibrous dosage forms for prolonged delivery of sparingly-soluble tyrosine kinase inhibitors. Part 1: Dosage form design, and models of expansion, post-expansion mechanical strength, and drug release” [Int. J. Pharm. 653 (2024) 123428]
Get full text
Journal Article
WITHDRAWN: Gastroretentive fibrous dosage forms for prolonged delivery of sparingly-soluble tyrosine kinase inhibitors. Part 4: Experimental validation of the models of in vivo expansion, gastric residence time, and drug concentration in blood
Blaesi, Aron H., Richter, Henning, Saka, Nannaji
Published in International journal of pharmaceutics (25.03.2024)
Published in International journal of pharmaceutics (25.03.2024)
Get full text
Journal Article